Quinten, C.; Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium, Department of General Medical Oncology and Geriatric Medicine, University Hospitals Leuven, Herestraat 49, Leuven, 3000, Belgium
Kenis, C.; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium, Department of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium
Decoster, L.; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium
Debruyne, P. R.; Cancer Centre, General Hospital Groeninge, Kortrijk, Belgium & Positive Ageing Research Institute (PARI), Anglia Ruskin University, Chelmsford, United Kingdom
De Groof, I.; Department of Geriatric Medicine, Iridium Cancer Network Antwerp, St. Augustinus, Wilrijk, Belgium
Focan, C.; Department of Oncology, Clinique Saint-Joseph, CHC-Liège Hospital Group, Liege, Belgium
Cornelis, F.; Department of Medical Oncology, Cliniques Universitaires Saint-Luc, UCL, Brussels, Belgium
Verschaeve, V.; Department of Medical Oncology, GHDC Grand Hôpital de Charleroi, Charleroi, Belgium
Bachmann, C.; Department of Geriatric Medicine, AZ Sint-Lucas, Ghent, Belgium
Bron, D.; Department of Hematology, ULB Institut Jules Bordet, Brussels, Belgium
Luce, S.; Department Medical Oncology, University Hospital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium
Debugne, G.; Department of Geriatric Medicine, Centre Hospitalier de Mouscron, Mouscron, Belgium
Van den Bulck, H.; Department of Medical Oncology, Imelda Hospital, Bonheiden, Belgium
Goeminne, J. C.; Department of Medical Oncology, CHU-UCL-Namur, site Sainte-Elisabeth, Namur, Belgium
Baitar, A.; Department of Medical Oncology, ZNA Middelheim, Antwerp, Belgium
Geboers, K.; Centre for Oncology and Hematology, AZ Turnhout, Turnhout, Belgium
Petit, B.; Department of Medical Oncology, Centre Hospitalier Jolimon, La Louvière, Belgium
Langenaeken, C.; Department of Medical Oncology, Iridium Cancer Network Antwerp, AZ Klina, Brasschaat, Belgium
Van Rijswijk, R.; Department of Medical Oncology, ZNA Stuivenberg, Antwerp, Belgium
Specenier, P.; Department of Medical Oncology, University Hospital Antwerp, Antwerp, Belgium
JERUSALEM, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'oncologie médicale
Praet, J. P.; Department of Geriatric Medicine, CHU St-Pierre, Free Universities Brussels, Brussels, Belgium
Vandenborre, K.; Department of Medical Oncology, AZ Vesalius, Tongeren, Belgium
Lycke, M.; Cancer Centre, General Hospital Groeninge, Kortrijk, Belgium & Positive Ageing Research Institute (PARI), Anglia Ruskin University, Chelmsford, United Kingdom
Flamaing, J.; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium, Department of Chronic Diseases, Metabolism and Ageing – CHROMETA, KU Leuven, Leuven, Belgium
Milisen, K.; Department of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium, Department of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, KU Leuven, Leuven, Belgium
Lobelle, J. P.; Beernem, Belgium
Wildiers, H.; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium, Department of Oncology, KU Leuven, Leuven, Belgium
Zikos, E., Coens, C., Quinten, C., Ediebah, D. E., Martinelli, F., Ghislain, I., et al. (2016). The added value of analyzing pooled health-related quality of life data: A review of the EORTC PROBE initiative. Journal of the National Cancer Institute, 108(5), djv391.
King, M. T. (2011). A point of minimal important difference (MID): A critique of terminology and methods. Expert Review of Pharmacoeconomics & Outcomes Research, 11(2), 171.
Kane, R. C. (2008). The clinical significance of statistical significance. The Oncologist, 13(11), 1129–1133.
Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61(2), 102–109.
Terwee, C. B., Roorda, L. D., Dekker, J., Bierma-Zeinstra, S. M., Peat, G., Jordan, K. P., et al. (2010). Mind the MIC: Large variation among populations and methods. Journal of Clinical Epidemiology, 63(5), 524–534.
Wright, A., Hannon, J., Hegedus, E. J., & Kavchak, A. E. (2012). Clinimetrics corner: A closer look at the minimal clinically important difference (MCID). Journal of Manual & Manipulative Therapy, 20(3), 160–166.
Bedard, G., Zeng, L., Zhnag, L., Lauzon, N., Holden, L., Tsao, M., et al. (2014). Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer. Asia-Pacific Journal of Clinical Oncology, 10(2), 109–117.
Boyce, M. B., Browne, J. P., & Greenhalgh, J. (2014). The experiences of professionals with using information from patient-reported outcome measures to improve the quality of healthcare: A systematic review of qualitative research. BMJ Quality Safety, 23(6), 508–518.
Fiteni, F., Anota, A., Westeel, V., & Bonnetain, F. (2016). Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: A critical review. BMC Cancer, 16, 122. 10.1186/s12885-016-2152-1.
Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health related quality of life scores. Journal of Clinical Oncology, 16(1), 139–144.
King, M. T. (1996). The interpretation of scores form the EORTC quality of life questionnaire QLQ-C30. Quality of Life Research, 5(6), 555–567.
Bedard, G., Zeng, L., Lam, H., Cella, D., Zhang, L., Lauzon, N., et al. (2012). Meaningful change in oncology quality-of-life instruments: A systematic literature review. Expert Review of Pharmacoeconomics & Outcomes Research, 12(4), 475–483.
American Cancer Society. Treatments and side effects. Retrieved October 4, 2018, from http://www.cancer.org/treatment/treatmentsandsideeffects/index.
Coens, C., van der Graaf, W. T. A., Blay, J. Y., Chawla, S. P., Judson, I., Sanfilippo, R., et al. (2015). Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072). Cancer, 121(17), 2933–2941.
Quidde, J., Hegewisch Becker, S., Graven, U., Lerchenmueller, C., Killing, B., Depenbusch, R., et al. (2016). Quality of life in patients with metastatic colorectal cancer receiving maintenance therapy after first-line inductive treatment: A quality of life sub-analysis of the AIO KRK 0207 phase III trial. Annals of Oncology. 10.1093/annonc/mdw370.105.
NIH. U.S.National Library of Medicine. Retrieved October, 4, 2018, from https://clinicaltrials.gov/ct2/show/NCT02395172.
Wildiers, H., Heeren, P., Puts, M., Topinkova, E., Janssen-Heijnen, M., Extermann, M., et al. (2014). International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. Journal of Clinical Oncology, 32(24), 2595–2603.
Quinten, C., Kenis, C., Hamaker, M., Coolbrandt, A., Brouwers, B., Dal Lago, L., et al. (2018). The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥ 70 with early stage invasive breast cancer. Journal of Geriatric Oncology, 9(2), 152–162.
Wedding, U., Röhrig, B., Klippstein, A., Brix, C., Pientka, L., & Höffken, K. (2007). Co-morbidity and functional deficits independently contribute to quality of life before chemotherapy in elderly cancer patients. Support Care Cancer, 15, 1097–1104.
Ediebah, D., Quinten, C., Coens, C., Ringash, J., Dancey, J., Zikos, E., et al. (2018). Quality of life as prognostic indicator of survival: A pooled analysis of individual patient data from Canadian Cancer Trials Group clinical trials. Cancer, 124(16), 3409–3416.
Folstein, M. F., Foldestein, S. E., & McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198.
Katz, S. (1983). Assessing self-maintenance: Activities of daily living, mobility, and instrumental activities of daily living. Journal of the American Geriatrics Society, 31(12), 721–727.
Lawton, M. P., & Brody, E. M. (1969). Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist, 9(3), 179–186.
Vellas, B., Guigoz, Y., Garry, P. J., Nourhashemi, F., Bennahum, D., Lauque, S., et al. (1999). The mini nutritional assessment (MNA-SF) and its use in grading the nutritional state of elderly patients. Nutrition, 15(2), 116–122.
Sheikh, J. I., & Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clinical Gerontologist, 5(1/2), 165–173.
Jensen, M. P., Chen, C., & Brugger, A. M. (2003). Interpretation of visual analogue scale rating and change scores: A reanalysis of two clinical trials of postoperative pain. The Journal of Pain, 4(7), 407–411.
Drasgow, F. (2006). Polychoric and polyserical correlations. Encyclopedia of Statistical Sciences. 10.1002/0471667196.ess2014.pub2.
Samsa, S., Edelman, D., Rothman, M. L., Williams, G. R., Lipscomb, J., & Matchar, D. (1999). Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics, 15(2), 141–155.
Eton, D., Cella, D., Yost, K. J., Yount, S. E., Peterman, A. H., Neuberg, D. S., et al. (2004). A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoint in a breast cancer scale. Journal of Clinical Epidemiology, 57(9), 898–910.
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592.
Hjermstad, M. J., Fossa, S. D., Bjordal, K., & Kaasa, S. (1995). Test/retest study of the European Organization for research and treatment of cancer core quality of life questionnaire. Journal of Clinical Oncology, 13(5), 1249–1254.
Cella, D., Eton, D. T., Lai, J., Peterman, A. H., & Merkel, D. E. (2002). Combining anchor and distribution-based methods to derive minimal clinically important differences on the Function Assessement of Cancer Therapy (FACT) Anemia and Fatigue Scales. Journal of Pain and Symptom Management, 24(6), 547–561.
Szumilas, M. (2010). Explaining odds ratios. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 19(3), 227–229.
Tashjian, R. Z., Deloach, J., Porucznik, C. A., & Powell, A. P. (2009). Minimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scale (VAS) measuring pain in patients treated for rotator cuff disease. Journal of Shoulder and Elbow Surgery, 18(6), 927–932.
Vinkers, D. J., Gussekloo, J., Stek, M. L., Westendorp, R. G., & Van Der Mast, R. C. (2004). The 15-item Geriatric Depression Scale (GDS-15) detects changes in depressive symptoms after a major negative life event. The Leiden 85-plus study. International Journal of Geriatric Psychiatry, 19(1), 80–84.
Cocks, K., King, M. T., Velikova, G., de Castro Jr. G., Martyn St-James, M., Fayers, P. M., Brown, J. M. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48(11), 1713–1721.
Nordin, A., Taft, C., & Lundgren-Nilsson, D. A. (2016). Minimal important differences for fatigue patient reported outcome measures—A systematic review. BMC Medical Research Methodology, 16, 62. 10.1186/s12874-016-0167-6.
Ringash, J., O’Sullivan, B., & Bezjak, A. (2007). Interpreting clinically significant changes in patient-reported outcomes. Cancer, 110(1), 196–202.
Cohen, J. (1998). Statistical power analysis for the behavioural sciences. New York: Academic New York.
Howard, G. S., Ralph, K. M., Gulanick, N. A., Maxwell, S. E., Nance, D. W., & Gerber, S. K. (1979). Internal invalidity in pretest-posttest self-report evaluations and a re-evaluation of retrospective pretests. Applied Psychological Measurement, 3(1), 1–23.
Oort, F. H., Visser, M. R. M., & Spranger, M. A. G. (2005). An application of structural equation modelling to detect response shifts and true change in quality of life data from cancer patients undergoing invasive surgery. Quality of Life Research, 14(3), 599–609.
Anota, A., Bascoul-Mollevi, C., Conroy, T., Guillemin, F., Velten, M., Jolly, D., et al. (2014) Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients. Health and Quality of Life Outcomes, 12, 32. 10.1186/1477-7525-12-32.
Verdam, M. G. E., Oort, F. J., & Sprangers, M. A. G. (2017). Structural equation modelling – based effect-size indices were used to evaluate and interpret the impact of response shift effects. Journal of Clinical Epidemiology, 85, 37–44.
Ousmen, A., Conroy, T., Guillemin, F., Velten, M., Jolly, D., Mercier, M., et al. (2016). Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time. Health and Quality of Life Outcomes, 15, 167. 10.1186/s12955-016-0569-5.
Scott, N. W., Fayers, P. M., Aaronson, N. K., Bottomley, A., de Graeff, A., Groenveld, M., et al. (2010) Differential item functioning (DIF) analyses of health-related quality of life instrument using logistic regression. Health and Quality of Life Outcomes, 8, 81. 10.1186/1477-7525-8-81.
Musoro, Z. J., Hamel, J. F., Ediebah, D. E., Cocks, K., King, M. T., Groenveld, M., et al. (2018). Establishing anchor-based minimally import differences (MID) with the EORTC quality-of-life measures: A meta-analysis protocol. British Medical Journal Open, 8, e019117. 10.1136/bmjopen-2017-019117.
